Cell Transplantation for the Treatment of Acute Myocardial Infarction Using Vascular Endothelial Growth Factor-Expressing Mesenchymal Stem Cells
Cell Transplantation for the Treatment of Acute Myocardial Infarction Using Vascular Endothelial Growth Factor-Expressing Mesenchymal Stem Cells
批准号:
14570685
负责人:
YOSHIYAMA Minoru
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Vascular endothelial growth factor (VEGF) may be a therapeutic reagent for ischemic region by inducing angiogenesis. Mesenchymal stem cells (MSCs) have multiple differentiated potential including cardiomyocytes. Therefore, we hypothesized that transplantation of VEGF-expressing MSCs could effectively treat myocardial infarction by providing VEGF-induced cardioprotection, followed by angiogenesis in ischemic myocardium combined with the functional benefits of MSCs-derived cells. Bone marrow mononuclear cells of Lewis rats were cultured with low glucose DMEM for MSCs outgrowth. MSCs were transfected with adenovirus expressing human VEGF_<165> and/or beta-galactosidase (lac Z). Six million of VEGF and lac Z transfected MSCs (VEGF group, n=8), lac Z transfected MSCs (Cont group, n=7), or medium only (M group, n=10) were injected into infarcted myocardium of syngeneic rat after left coronary artery occlusion for one hour. At one week after the injection, lac Z-expression cells were immunohi … More stochemically detected in VEGF group and Cont group. Moreover, positive finding against VEGF polyclonal antibody was increased in VEGF group than in Cont group. At four weeks, infarct size (VEGF; 26.3, Cont; 31.4, M; 38.0 %, P<0.05) was significantly reduced in VEGE group, compared with M group. By echocardiography assessment, left ventricular end-diastolic dimension was significantly lower in the VEGF group, compared with M group (VEGF; 9.9, Cont; 10.2, M; 10.8 mm, p<0.01). Left ventricular fractional shortening (VEGF; 20.0, Cont; 17.7, M; 10.7 %, P<0.05) and ejection fraction (VEGF; 48.3, Cont; 43.6, M; 28.6 %, P<0.05) were significantly higher in VEGF group and Cont group. By light microscopy, increased number of capillaries was observed in infarcted area of VEGF group. Under electoron microscopy, many spindle-shaped interstitial cells and small cells containing myofilaments were observed adjacent to the infarcted area both in VEGF group and Cont group. Furthermore, the spindle-shaped cells were often making point-to-point contact each other and arranged helically around a lumen in VEGF group. In conclusion, this combined strategy of cell transplantation with gene therapy could be important for the treatment of acute myocardial infarction. Less
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Omura T, Yoshiyama M, Yoshida K, Nakamura Y, Kim S, Iwao H, Takeuchi K, Yoshikawa J: "Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine"Hypertension. 39. 81 (2002)
Omura T、Yoshiyama M、Yoshida K、Nakamura Y、Kim S、Iwao H、Takeuchi K、Yoshikawa J:“c-Jun 的显性阴性突变体抑制内皮素 1 和去氧肾上腺素诱导的心肌细胞肥大”高血压。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Omura T, Yoshiyama M, Kim S, Iwao H, Takeudchi K, Yoshikawa J.: "Dominant Negative Mutant of c-Jun Inhibits Cardiomyocyte Hypertrophy Induced by Endothelin 1 and Phenylephrine"Hypertension. 39. 81-86 (2002)
Omura T、Yoshiyama M、Kim S、Iwao H、Takeudchi K、Yoshikawa J.:“c-Jun 的显性阴性突变体抑制内皮素 1 和去氧肾上腺素诱导的心肌细胞肥大”高血压。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shirai N, Yamagishi H, Yoshiyama M, Teragaki M, Akioka K, Takeuchi K, Yoshikawa J, Ochi H: "Incremental value of assessment of regional wall motion for detection of multivessel coronary artery disease in exercise (201)Tl gated myocardial perfusion imaging
Shirai N、Yamagishi H、Yoshiyama M、Teragaki M、Akioka K、Takeuchi K、Yoshikawa J、Ochi H:“运动 (201)Tl 门控心肌灌注成像中区域壁运动评估对检测多支冠状动脉疾病的增量价值
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakamura Y, Yoshiyama M, Omura T, Takeuchi K, Yoshikawa J.: "Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction"Cardiovasc Res.. 57. 48-54 (2003)
Nakamura Y、Yoshiyama M、Omura T、Takeuchi K、Yoshikawa J.:“ACE抑制剂和血管紧张素II 1型受体阻滞剂联合使用对大鼠心肌梗死心脏重塑的有益作用”Cardiovasc Res.. 57. 48-54 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Izutani S, Yoshiyama M, Omura T, Yoshida K, Nakamura Y, Kim S, Takeuchi K, Yoshikawa J: "Nipradilol can prevent left ventricular systolic and diastolic dysfunction after myocardial infarction in rats"Circulation Journal. 66. 289 (2002)
Izutani S、Yoshiyama M、Omura T、Yoshida K、Nakamura Y、Kim S、Takeuchi K、Yoshikawa J:“尼普地洛可以预防大鼠心肌梗死后左心室收缩和舒张功能障碍”循环杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
The effect of cardiac rehabilitation on the myokines in patients with heart failura
-
批准号:24591066
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:YOSHIYAMA Minoru
-
依托单位:
The Role of Side Population Cell in Skeletal Muscle on post infarcted LV remodeling
-
批准号:18590785
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.49万
-
财政年份:2006
-
负责人:YOSHIYAMA Minoru
-
依托单位:
The pathophysiology of cardiac and vascular remodeling and gene therapy
-
批准号:12670684
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:YOSHIYAMA Minoru
-
依托单位:
海外基金